EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules.
EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules.
复制标题
DOI:
10.7150/thno.78395
复制
发表时间:
2023
期刊:
影响因子:
12.4
通讯作者:
Cheung AKL
中科院分区:
文献类型:
--
作者:
Liu Y;Lui KS;Ye Z;Fung TY;Chen L;Sit PY;Leung CY;Mak NK;Wong KL;Lung HL;Tanaka Y;Cheung AKL
Nasopharyngeal carcinoma (NPC) is a diverse cancer with no well-defined tumor antigen, associated with oncogenic Epstein-Barr Virus (EBV), and with usually late-stage diagnosis and survival <40%. Current radiotherapy and chemotherapy have low effectiveness and cause adverse effects, which calls for the need of new therapy. In this regard, adoptive immunotherapy using γδ T cells has potential, but needs to be coupled with butyrophilin 2A1 and 3A1 protein expression to achieve tumoricidal effect. Methods: Human γδ T cells were expanded (with Zol or PTA) and used for cytotoxicity assay against NPC cells, which were treated with the EBV EBNA1-targeting peptide (L2)P4. Effect of (L2)P4 on BTN2A1/BTN3A1 expression in NPC cells was examined by flow cytometry and Western blot. An NPC-bearing NSG mice model was established to test the effectiveness of P4 and adoptive γδ T cells. Immunofluorescence was performed on NPC tissue sections to examine the presence of γδ T cells and expression of BTN2A1 and BTN3A1. EBV gene expression post-(L2)P4 treatment was assessed by qRT-PCR, and the relationship of LMP1, NLRC5 and BTN2A1/BTN3A1 was examined by transfection, reporter assay, Western blot, and inhibition experiments. Results: Zol- or PTA-expanded the Vδ2 subset of γδ T cells that exerted killing against certain NPC cells. (L2)P4 reactivates latent EBV, which increased BTN2A1 and BTN3A1 expression and conferred higher susceptibility towards Vδ2 T cells cytotoxicity in vitro, as well as enhanced tumor regression in vivo by adoptive transfer of Vδ2 T cells. Mechanistically, (L2)P4 induced EBV LMP1, leading to IFN-γ/p-JNK and NLRC5 activation, and subsequently stimulated the expression of BTN2A1 and BTN3A1. Conclusions: This study demonstrated the effectiveness of using the EBV-targeting probe (L2)P4 and adoptive γδ T cells as a promising combinatorial immunotherapy against NPC. The identification of the LMP1-IFN-γ/p-JNK-NLRC5-BTN2A1/BTN3A1 axis may lead to new insight and therapeutic targets against NPC and other EBV+ tumors.
登录
查看更多内容
影响因子:
16.6
作者:
Liu Y;He S;Wang XL;Peng W;Chen QY;Chi DM;Chen JR;Han BW;Lin GW;Li YQ;Wang QY;Peng RJ;Wei PP;Guo X;Li B;Xia X;Mai HQ;Hu XD;Zhang Z;Zeng YX;Bei JX
通讯作者:
Bei JX
影响因子:
11.4
作者:
Gires, O;Kohlhuber, F;Hammerschmidt, W
通讯作者:
Hammerschmidt, W
影响因子:
7.5
作者:
Cheung, Allen Ka Loon;Huang, Yiru;Chen, Zhiwei
通讯作者:
Chen, Zhiwei
影响因子:
4.5
作者:
Abdulamir, A. S.;Hafidh, R. R.;Abdulmuhaimen, N.;Abubakar, F.;Abbas, K. A.
通讯作者:
Abbas, K. A.
影响因子:
5.4
作者:
Bentz, Gretchen L.;Whitehurst, Christopher B.;Pagano, Joseph S.
通讯作者:
Pagano, Joseph S.